Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Research Across America
mi
from
Dallas, TX
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Research Across America
mi
from
Katy, TX
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Research Across America
mi
from
Katy, TX
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
mi
from
West Jordan, UT
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Partners, LLC
mi
from
Henrico, VA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Partners, LLC
mi
from
Henrico, VA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Translational Research Group, INC., d/b/a Providence Clinical Research
mi
from
Burbank, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Translational Research Group, INC., d/b/a Providence Clinical Research
mi
from
Burbank, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Cahaba Research
mi
from
Birmingham, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Cahaba Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Arrowhead Family Health Center PC dba Arrowhead Health Centers
mi
from
Glendale, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Arrowhead Family Health Center PC dba Arrowhead Health Centers
mi
from
Glendale, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Advanced Research Associates
mi
from
Glendale, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Advanced Research Associates
mi
from
Glendale, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Trials, LLC
mi
from
Phoenix, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Trials, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Genova Clinical Research
mi
from
Tucson, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Genova Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Advanced Rx Clinical Research
mi
from
Artesia, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Advanced Rx Clinical Research
mi
from
Artesia, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
GW Research Inc,
mi
from
Chula Vista, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
GW Research Inc,
mi
from
Chula Vista, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Community Clinical Trials
mi
from
Orange, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Healthcare Partners Medical Group
mi
from
Pasadena, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Healthcare Partners Medical Group
mi
from
Pasadena, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Memorial Research Medical Clinic d/b/a Orange Country Research Center
mi
from
Tustin, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Memorial Research Medical Clinic d/b/a Orange Country Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Lynn Institute of the Rockies
mi
from
Colorado Springs, CO
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Lynn Institute of the Rockies
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Consultants for Clinical Research of South Florida
mi
from
Boynton Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Consultants for Clinical Research of South Florida
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medical Research Unlimited
mi
from
Hialeah, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medical Research Unlimited
mi
from
Hialeah, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Eastern Research, Inc.
mi
from
Hialeah, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Eastern Research, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Health Awareness
mi
from
Jupiter, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Health Awareness
mi
from
Jupiter, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Jupiter Research
mi
from
Jupiter, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Jupiter Research
mi
from
Jupiter, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
MNH Surgical Center
mi
from
Maitland, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
MNH Surgical Center
mi
from
Maitland, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Columbus Clinical Services, LLC
mi
from
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Columbus Clinical Services, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
South Medical Research Group, Inc
mi
from
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
South Medical Research Group, Inc
mi
from
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Genoma Research Group, Inc.
mi
from
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Genoma Research Group, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
San Marcus Research Clinic
mi
from
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
mi
from
Orlando, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Urology Center of Florida
mi
from
Pompano Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Urology Center of Florida
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Accord Clinical Research
mi
from
Port Orange, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Tampa, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Central Florida
mi
from
Winter Haven, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Augusta University
mi
from
Augusta, GA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Mount Vernon Clinical Research, LLC
mi
from
Sandy Springs, GA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Mount Vernon Clinical Research, LLC
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
CTL Research
mi
from
Eagle, ID
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
CTL Research
mi
from
Eagle, ID
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medex Healthcare Research, Inc.
mi
from
Chicago, IL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medex Healthcare Research, Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Augusta, KA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Augusta, KA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Research Integrity, Llc
mi
from
Owensboro, KY
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Research Integrity, Llc
mi
from
Owensboro, KY
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Delta Research Partners, LLC
mi
from
Bastrop, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Delta Research Partners, LLC
mi
from
Bastrop, LA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Click here to add this to my saved trials